Navigating the Future: Small Molecule Drug Discovery Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Small Molecule Drug Discovery Market Size Growth Forecast: What to Expect by 2025?
There has been robust growth in the small molecule drug discovery market in recent years. This market is projected to rise from $62.44 billion in 2024 to $67.94 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.8%. The significant growth seen in the past can be credited to factors such as initiatives to repurpose drugs, the automation of drug discovery, a boost in r&d investments, regulatory backing for drug development, and improvements in high-throughput screening.

How Will the Small Molecule Drug Discovery Market Size Evolve and Grow by 2029?
It is anticipated that the market size for small molecule drug discovery will experience an accelerated growth within the upcoming years. The market is projected to reach "$104.6 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.4%. This projected growth during the forecast period is linked to the introduction of new therapeutic targets, patient-focused drug discovery, combined drug-device products, application of real-world evidence, integration of pharmacogenomics, and worldwide health issues. Key developments expected in the forecast period include fragment-based drug discovery, incorporation of artificial intelligence in drug discovery, RNA-targeted therapeutics, collaborations, and partnerships, novel drug delivery innovations, and the increasing use of organoids and 3d cell culture models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

What Drivers Are Propelling the Growth of Small Molecule Drug Discovery Market Forward?
The small molecule drug discovery market is predicted to grow due to the increasing prevalence of chronic illnesses. Chronic illnesses are long-term conditions that interfere with daily activities and need ongoing medical care. These conditions, such as HIV, cancer, infections, heart disease, and kidney disease, can be managed with small-molecule drugs, which tend to be more cost-effective for patients. Therefore, the higher rates of chronic illnesses are anticipated to enhance the small molecule drug discovery market. As an example, a study by the US-based biomedical research agency, the National Institutes of Health (NIH), forecasts that, by 2023, the count of individuals aged 50 and above in the US with at least one chronic condition will increase by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Alongside this, the figure of individuals with multimorbidity is expected to surge from 7.8304 million in 2020 to 14.968 million in 2050, a rise of 91.16%. Thus, the escalating prevalence of chronic diseases is propelling the expansion of the small molecule drug discovery market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What Are the Key Trends Driving Small Molecule Drug Discovery Market Growth?
The rise in technological advancements is a prominent trend noted in the small molecule drug discovery sector. The focus of the major players in this market is on creating innovative products. As an example, in January 2023, a digital science platform provider from the USA known as Dotmatics, introduced their Small Molecule Drug Discovery Solution. This particular product is distinctively structured with an incorporated scientific R&D platform which includes pre-configured workflows along with enhanced data management capabilities. It not only addresses the issue of operational inefficiencies but also accelerates the journey from insights to decisions.

What Are the Key Segments in the Small Molecule Drug Discovery Market?
The small molecule drug discovery market covered in this report is segmented -

1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:
1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs
2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

Who Are the Key Players Shaping the Small Molecule Drug Discovery Market's Competitive Landscape?
Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

What Geographic Markets Are Powering Growth in the Small Molecule Drug Discovery Market?
North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9834

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.